Assessment of p53 protein expression in normal, benign, and malignant oral mucosa

The Journal of Pathology

Volumn 166, Issue 4, 1992, Pages 389-394

  Ogden, Graham R ^a   Kiddie, Roy A ^a   Lunny, Declan P ^a   Lane, David P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

oncogene; oral cancer; oral cytology; oral mucosa; p53; tumour suppressor gene

Indexed keywords

PROTEIN P53;

ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; MOUTH CARCINOMA; MOUTH MUCOSA; PAPILLOMA; PRIORITY JOURNAL; SUPPRESSOR GENE;

EID: 0026534598     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711660411     Document Type: Article

References (38)

1. Epidemiology of mouth cancer in 1989: a review
2. Cancer statistics 1991
3. Cancer of the head and neck: are we doing any better?
4. Oral cancer: the behaviour and response to treatment of 194 cases
5. Oral Cancer
6. An immunohisto‐chemical assessment of cellular proliferation markers in head and neck squamous cell cancers
7. Mutation of the p53 gene and accumulation of the p53 protein: common steps found in the majority of human cancers
8. p53: oncogene or anti‐oncogene?
9. p53 mutations in human cancer
10. Regulation of the level of the oncoprotein p53 in non‐transformed and transformed cells
11. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro
12. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
13. The p53 proto‐oncogene can act as a suppressor of transformation
14. p53: a frequent target for genetic abnormalities in lung cancer
15. Mutations in the p53 gene are frequent in primary resected non‐small cell lung cancer
16. Increased expression of mutant form of p53 oncogene in primary lung cancer
17. Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry
18. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
19. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in E. coli
20. Mutations in the p53 gene occur in diverse human tumour types
21. Overexpression and mutation of p53 in epithelial ovarian cancer
22. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
23. Human papillomavirus (HPV) infections and their associations with oral disease
24. Detection of human papillomavirus‐genomic DNA in oral epithelial dysplasias, oral smokeless tobacco‐associated leukoplakias, and epithelial malignancies
25. Detection of human papillomavirus (HPV) DNA in oral squamous cell carcinomas by in situ hybridization and polymerase chain reaction
26. Detection of human papillomavirus in head and neck tumors with DNA hybridization and immunohistochemical analysis
27. In situ DNA hybridization analysis of oral papillomas, leukoplakias and carcinomas for human papillomavirus
28. In situ hybridization analysis of human papillomavirus DNA in oral mucosal lesions
29. Detection of human papillomarvirus DNA in biopsies of human oral tissue
30. In situ detection of HPV DNA in oral mucosal lesions. A comparison of two hybridization kits
31. An epidemiological study of oral and pharyngeal cancer in central and South East Asia
32. Quantitative exfoliative cytology of abnormal oral mucosal smears
33. Quantitative cytophotometric analysis as an aid to the detection of recurrent oral cancer
34. DNA measurements–an objective predictor of response to irradiation?. A review of 24 squamous cell carcinomas of the oral cavity
35. DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas
36. The p53 tumour suppressor gene
37. Second malignant tumours in head and neck cancer